Affected by market rumors, China Meheco Group Co.Ltd(600056) share price rose for three consecutive days, and China Meheco Group Co.Ltd(600056) issued announcements on March 3 and March 4, shouting that investors “pay attention to risks and invest prudently”.
On the 3rd, China Meheco Group Co.Ltd(600056) released the announcement on abnormal fluctuations in stock trading, which mentioned that the company was concerned about the recent rumors of cooperation between the company and covid-19 virus treatment drugs of a multinational pharmaceutical company in market after verification by the company, relevant matters are under communication and negotiation, and there is still uncertainty. If the cooperation is carried out smoothly, the final use and sales of relevant drugs are also affected by factors such as epidemic prevention and control, and there is uncertainty, which has no significant impact on the company’s recent operating performance.
China Meheco Group Co.Ltd(600056) said that according to the system query, the company’s dynamic P / E ratio was 12.88 times as of the closing on March 3, 2022. Please pay attention to the trading risks in the secondary market, make rational decisions and invest prudently.
Nevertheless, the enthusiasm of investors remained unabated, and the trading limit of China Meheco Group Co.Ltd(600056) opened on March 4. On the 4th, China Meheco Group Co.Ltd(600056) issued a risk warning and further disclosed the information that “even if the cooperation is carried out smoothly, the final use and sales of relevant drugs are affected by factors such as epidemic prevention and control, there is great uncertainty, and it is estimated that the scale of relevant business accounts for a small proportion of the company’s overall business volume , which has no significant impact on the company’s recent operating performance.”
China Meheco Group Co.Ltd(600056) said that the stock price of the company fluctuated greatly recently, and the increase of may have exceeded the impact of relevant matters on the company’s performance . Please invest prudently and pay attention to investment risks.
Recently, China Meheco Group Co.Ltd(600056) issued the announcement on performance reduction in 2021. It is estimated that the net profit attributable to shareholders of Listed Companies in 2021 will be 300 million yuan to 700 million yuan, a year-on-year decrease of 77% to 47% compared with the same period of last year. The net profit attributable to shareholders of listed companies after deducting non recurring profits and losses was 250 million yuan to 650 million yuan, a year-on-year decrease of 79% to 45% compared with the same period of last year. The specific and accurate financial data shall be subject to the audited annual report of 2021 officially disclosed by the company.
According to the information on China Meheco Group Co.Ltd(600056) official website, China Meheco Group Co.Ltd(600056) is a state-controlled listed company listed on Shanghai Stock Exchange. In recent years, the company has initially established an integrated industrial pattern of trade, industry, technology and service led by international trade, supported by the pharmaceutical industry and linked by the pharmaceutical business. The industrial form involves the whole industrial chain of planting and processing, R & D, production, sales, logistics, import and export trade, academic promotion, technical services and so on.
According to the data, as of the closing on March 4, China Meheco Group Co.Ltd(600056) rose by the limit of 14.77 yuan, and the share price reached a new high since January 2021.
